Tech Company Financing Transactions
Oraya Therapeutics Funding Round
Private investors participated in a $25.1 million capital raise for Oraya Therapeutics. The round closed on 5/13/2014.
Transaction Overview
Company Name
Announced On
5/13/2014
Transaction Type
Venture Equity
Amount
$25,132,051
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8000 Jarvis Ave. 200
Newark, CA 94560
USA
Newark, CA 94560
USA
Phone
Website
Email Address
Overview
Founded in 2006, Oraya's first commercial application, the IRay system, is currently undergoing clinical trials for the treatment of wet age-related macular degeneration (AMD).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Taylor
Chief Financial Officer
Ed Battle
VP - Bus. Development
Alan Czeszynski
VP - Regulatory Affairs
Astrid Berthe
Browse more venture capital transactions:
Prev: 5/13/2014: GridPoint venture capital transaction
Next: 5/13/2014: Shareablee venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs